Q2 roll call for mid-sized pharma, as companies face generics trough

Deborah Weinstein

August 01 2012

First-half earnings are in for Allergan, Shire and UCB, with the three companies striking an upbeat tone on revenues.

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.